Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

Baselga, José; Cortés, Javier; Kim, Sung‐Bae; Im, Seock‐Ah; Hegg, Roberto; Im, Young‐Hyuck; Roman, Laslo; Luiz Pedrini, José; Pieńkowski, Tadeusz; Knott, Adam; Clark, Emma; Benyunes, Mark; Ross, Graham; M. Swain, Sandra

doi:10.1056/nejmoa1113216

Public

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

Published in New England Journal of Medicine • Dec 7, 2011

Authors:

José Baselga

Javier Cortés

Sung‐Bae Kim

Abstract

BACKGROUND: The anti-human epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody trastuzumab improves the outcome in patients with HER2-positive metastatic breast cancer. However, most cases of advanced disease eventually progress. Pertuzumab, an anti-HER2 humanized monoclonal anti...

Subject

Pertuzumab

Medicine

Trastuzumab

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!